News

Featured

Imperial College London's 'Science in Medicine School Teams Prize 2024' now open for entries

The Scleroderma and Raynaud’s UK sponsored 'Science in Medicine School Teams Prize 2024' contest is now open for entries. The contest aims to engage sixth form school students with science in medicine, and challenges students to prepare an ePoster with a novel vision on how to promote the health and well-being of individuals with Scleroderma and/or Raynaud’s. If you're interested in entering, or know someone in sixth form who might be, read on to find out more!

Featured

SRUK says Energy companies must step up support for people with Raynaud's.

As high bills continue to threaten the health of those living with the debilitating condition; SRUK is appealing to energy companies to provide financial assistance to them.

Featured

Time to move on from 'Doctor Knows Best'

SRUK Chief Executive says: ‘Time to move on from Doctor Knows Best’ As study finds Patient views not always valued

Wednesday 19th July 2023

The OASIS project: SRUK-funded research builds evidence for new methods of skin assessment in Scleroderma

A recently completed SRUK-funded research project, led by Dr Peter Worsley at the University of Southampton, has built evidence for the use of non-invasive tools which can accurately measure the health of the skin in Scleroderma. The findings of the project have the potential to drive forward the use of new, non-invasive skin assessment methods, using tools employed in the assessment of other conditions that affect the skin, which could be an important step towards improving the diagnosis and monitoring of the condition.

Read Article

Friday 15th July 2022

Six Months of STAR – the Symptom Tracking App for Raynaud’s

July marks six months since Scleroderma & Raynaud’s UK launched STAR, the Symptom Tracking App for Raynaud’s, which enables members of the SRUK community to track their Raynaud's attacks and directly contribute to essential scientific research into the condition. Here’s a breakdown of what we’ve learnt so far, thanks to the STAR community!

Read Article

Thursday 29th July 2021

Could I be at risk? What we know so far about immune responses to the COVID-19 vaccination in those with weakened immune systems

As the UK strives to give every adult their COVID-19 vaccinations, what do we know about their effectiveness in protecting those with weakened immune systems such as some individuals with scleroderma?

Read Article

Thursday 22nd July 2021

Touching on Touchscreens - Making Technology More Accessible for People With Scleroderma

Are you reading this from a touchscreen device? Using touchscreen technology is something many of us do every day, without even thinking about it. But what happens to the people who have conditions that make touchscreens tough?

Read Article

Thursday 8th July 2021

Collaboration is Key: Developing a New Diagnostic Tool for Scleroderma

“We are limited by current assessment tools such as the skin score, which is limited by subjectivity, as well as the time needed for training and standardisation. We need to make sure that new treatments are evaluated in the best and most robust way so that we can make more progress and discontinue approaches that do not work.” Prof. Chris Denton

Read Article

Tuesday 18th July 2017

Autologous lipotransfer utilises the patient’s own cells to reverse the effects of fibrosis

This pioneering and innovative new treatment option is to treat fibrosis of the face and other tissues in people with scleroderma. The technique is known as autologous lipotransfer and utilises the patient’s own cells to reconstruct facial tissue and reverse the effects of fibrosis and internal scarring.

Read Article